Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback